Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review
Introduction Metabolic dysfunction-associated fatty liver disease (MASLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease worldwide. Given that there is no pharmacological treatment for MASLD, it is imperative to understand whether lifestyle modifica...
Main Authors: | David Armstrong, Simon Oczkowski, Constantine Jason Karvellas, Joanna Dionne, Kasey Moss, Victor Gitman, M Ines Pinto Sanchez, Saumya Jayakumar, Nazia Selzner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/4/e079750.full |
Similar Items
-
Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
by: Katharina Staufer, et al.
Published: (2023-07-01) -
Iron, Oxidative Stress, and Metabolic Dysfunction—Associated Steatotic Liver Disease
by: Sophie Gensluckner, et al.
Published: (2024-02-01) -
9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes
by: Adriana R. Schultz Moreira, et al.
Published: (2020-11-01) -
A systematic review and meta-analysis of the effects of non-pharmacological interventions on quality of life in adults with multiple sclerosis
by: Victor Gitman, et al.
Published: (2023-08-01) -
Does Resveratrol Improve Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)?
by: Kamila Kasprzak-Drozd, et al.
Published: (2024-03-01)